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1. Zusammenfassung   
1.1 Einleitung 
Die Applikation einer Kraft auf einen Zahn im Rahmen einer kieferorthopädischen 
induzierten Zahnbewegung führt zu einer initialen Auslenkung des Zahnes innerhalb 
seiner Alveole, sodass einige Teile des Desmodontalspaltes sich verschmälern 
(„Druckzone“) und gegenüberliegenden Teile sich verbreitern („Zugzone“). 
Aufgrund von Zirkulationsveränderungen, Zelldeformation, oder Kompression der 
Nervenenden erfolgt eine Freisetzung verschiedener Faktoren, die eine Resorption des 
Alveolarknochens auf der Druckzone und eine Knochenapposition auf der Zugzone 
verursachen. 
IGFs stellen eine Familie von Wachstumsfaktoren dar, die aus 2 Liganden, IGF-I/II, 2 
Rezeptoren, IGF-IR/IIR, und 6 Bindungsproteinen, IGFBP-1 bis IGFBP-6, bestehen. 
IGF-I stellt einen wichtigen Faktor für postnatales Wachstum dar. Er wirkt sowohl 
endokrin als auch para- und autokrin auf systemischer als auch auf lokaler Ebene. Im 
Bindegewebe und im Knochen wird IGF-I von Osteoblasten und Fibroblasten 
produziert und in die Matrix eingelagert. Es stimuliert Differenzierung und 
Proliferation und hemmt die Apoptose dieser Zellen. Nach Bindung von IGF-I an IGF-
IR werden 3 intrazelluläre Signalwege aktiviert. IRS-1 ist dabei das wichtigste 
Substrat für die Vermittlung der IGF-I-Signale.  
Knochen und Bindegewebe empfangen mechanische Belastungen, die für ihre 
Integrität und Ihr Remodelling von Bedeutung sind, was zur Freisetzung verschiedener 
Faktoren führt. In vielen Geweben und Zellarten induziert die mechanische Belastung 
auch eine IGF-I-Expression. In neuen Studien konnten alle Moleküle des IGF-Systems 
im Parodont des Menschen und der Ratte nachgewiesen werden. Des Weiteren 
konnten Studien zeigen, dass Dehnungen der Zellen eine Modulation der 
Genexpression verschiedener IGF-Familienmitglieder zur Folge hatten. 
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1.2 Zielsetzungen und Hypothesen der vorliegenden Studie 
In der vorliegenden Untersuchung sollte überprüft werden: 
1. ob lokal produziertes IGF-I an der Mechanotransduktion von Zellen des Parodontal-
ligaments (PDL) während der frühen Phase der Zahnbewegung beteiligt ist, 
2. ob es ein differenziertes Expressionsmuster von IGF-I, IGF-IR und IRS1 in Druck- 
und  Zugzonen gibt, 
3. und ob die Veränderungen bzw. die Verteilung des IGF-I von der Größe der 
angewandten Kräfte abhängig sind. 
Darüberhinaus sollte die Bedeutung von IGF-I für die Umbauaktivitäten im Rahmen 
der orthodontischen Zahnbewegung diskutiert werden. 
1.3 Material und Methoden 
Der rechte obere erste Molar von 20 anästhetisierten Ratten wurde mit einer Kraft 
belastet, um den Zahn nach mesial zu bewegen. Konstante Kräfte von 0.1N,  0.25 N 
und 0.5 N wurden über 4 Stunden an 4 Versuchstieren verwendet. Die Kräfte wurden 
über einen Sensor für 4 Stunden gemessen. Weiterhin wurden konstante Kräfte von 0.1 
N über 2 Stunden in 8 weiteren Tieren angewandt. Im Anschluss wurden der erste und 
zweite Molar permanent mit Kunststoff separiert und die antagonistischen Molaren 
beschliffen. Vier Ratten aus der Gruppe wurden nach 1 Tag und  weitere 4 Ratten nach 
2 Tagen geopfert. Die unbehandelte kontralaterale Seite wurde als Kontrolle 
verwendet. Die präparierten Maxillae wurden in Paraffin eingebettet und schließlich in 
dünne sagittale Schnitte geschnitten. Immunohistologische Färbungen wurden zur 
Identifizierung von IGF-I, IGF-IR und IRS1 durchgeführt. Fotos wurden von der 
Druckseite (mesiokoronale Region) und von der Zugseite (distokoronale Region) 
aufgenommen und histomorphometrisch ausgewertet. Die statistische Auswertung 
erfolgte mit SPSS-Software. 
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1.4 Ergebnisse und Diskussion 
Alle untersuchten Faktoren waren im PDL der belasteten Gruppen und der 
Kontrollgruppe nachweisbar. Die Ergebnisse zeigten eine Zunahme der Anzahl der 
positiven Zellen aller untersuchten Faktoren auf der Zugzone. Im Vergleich mit der 
Kontrollgruppe waren alle Unterschiede signifikant und von der Zeitdauer der 
Belastung abhängig. Die höchste Zahl der IGF-IR-immunopositiven Zellen wurde 
nach 24 Stunden von der Kraftapplikation festgestellt. 
In der Druckzone fiel die Anzahl der positiven Zellen aller untersuchten Faktoren nach 
4 Stunden von der Kraftapplikation ab. Diese Abnahme war signifikant von der Höhe 
der applizierten Kräfte abhängig. Nach 24 bzw. 48 Stunden stieg die Anzahl der 
positiven Zellen wieder auf den Level der Kontrollgruppe an. 
Die Abnahme/Zunahme der positiven Zellen war tendenziell von der Kraftgröße 
abhängig. 
Diese Ergebnisse weisen auf eine Rolle von IGF-I in der Aufrechterhaltung der 
parodontalen Gewebshomöostase sowie den Umbauprozessen während der 
Zahnbewegung hin. Die Ergebnisse in der Zugzone stimmen mit denen anderer 
Autoren überein, die für andere Gewebe gezeigt haben, dass nach einer kurzfristigen 
Belastung die IGF-I-Expression in Sehnenzellen, Muskelzellen aber auch in 
Osteoblasten und Osteozyten zunimmt. 
Man kann auch davon ausgehen, dass IGF-I an Mechanotransduktionsvorgängen 
während der frühen Phasen der Zahnbewegung beteiligt ist. 
Diese IGF-I-Hochregulation könnte die Proliferation und die Differenzierung der 
PDL-Zellen stimulieren und die Apoptose beeinflussen.  
In der Druckzone zeigen die Ergebnisse, dass verminderte Expression der untersuchten 
Faktoren zur Verringerung der Proliferation und schließlich zur Abnahme der Anzahl 
der PDL-Zellen führen könnte. 
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1.5  Schlussfolgerung 
In der vorliegenden Studie wurde in einem Rattenmodell die Verteilung von IGF-I, 
IGF-IR und IRS1 während der frühen Phase der Zahnbewegung untersucht. 
Die erhobenen Daten deuten darauf hin, dass die lokale auto- und parakine Freisetzung 
von IGF-I eine frühe Reaktion der Zellen des PDLs auf eine orthodontische Belastung 
darstellt, und dass IGF-I an Mechanotransduktionsvorgängen beteiligt ist. Diese 
Reaktion ist tendenziell von der Größe der applizierten Kraft und eindeutig von 
Belastungszeit abhängig. Dies könnte zur Aktivierung bzw. Hemmung der 
Proliferation und Differenzierung der PDL-Zellen sowie zur Hemmung bzw. 
Auslösung von Apoptose führen. 
Die Ergebnisse dieser Studie tragen dazu bei, die Molekulare und zelluläre Grundlagen 
der kieferorthopädischen Zahnbewegung besser zu verstehen und die mit den 
klinischen Erfahrungen aus der Kieferorthopädie zu verknüpfen. 
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2. Introduction 
2.1 Tooth movement 
Orthodontic tooth movement has been defined as the result of a biologic response of 
periodontal ligament to an externally applied force (Proffit, 2007). 
The purpose of orthodontic treatment is to move teeth as efficiently as possible with 
minimal adverse effects for the teeth and supporting tissue. The predictability of tooth 
movement in humans is of clinical interest, particularly in terms of the nature and 
speed of tooth movement in response to specific applied mechanics and the absence of 
undesirable sequelae (Iwasaki et al., 2008). 
Mainly based on histological research, a pressure and a tension side are distinguished 
during orthodontic tooth movement. On the pressure side, the biological events are as 
follows: disturbance of blood flow in the compressed PDL, cell death in the 
compressed area of the PDL (hyalinization), resorption of the hyalinized tissue by 
macrophages, and undermining bone resorption by osteoclasts beside the hyalinized 
tissue, which ultimately results in tooth movement. On the tension side, blood flow is 
activated where the PDL is stretched, which promotes osteoblastic activity and osteoid 
deposition, which later mineralizes (Von Böhl and Kuijpers-Jagtman, 2009). 
 
2.1.1 The theories of tooth movement 
2.1.1.1 The pressure-tension theory  
According to the classic histological research by Sandstedt (1904), Oppenheim (1911) 
and Schwarz (1932), this theory states that a tooth moves in the periodontal space by 
generating a “pressure side” and a “tension side” (Krihnan and Davidovitch, 2006). 
In this theory, the blood flow decreases where the PDL is compressed, and maintains 
or increases where the PDL is under tension. These alterations create quickly changes 
in chemical environment (Proffit, 2007). 
The force-subjected PDL progenitor cells differentiate into compression associated 
osteoclasts and tension-associated osteoblasts, causing bone resorption and apposition, 
respectively. Direct resorption is associated with light force (frontal) application. 
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Indirect (undermining) resorption and hyalinization are associated with bio-intolerant 
heavy forces (Masella and Meister, 2006). 
 
2.1.1.2.1 The bone-bending theory 
According to Baumrind (1969) and Grimm (1972), this theory states that orthodontic 
forces produce alveolar bone deflection. The active biologic processes that follow 
bone bending involve bone turnover and renewal of cellular and inorganic fractions 
and are accompanied by changes in the PDL. These authors could explain facts such as 
(1) the relative slowness of en-masse tooth movement; (2) the velocity of tooth 
movement toward an extraction site; and (3) the relative rapidity of tooth movement in 
children, who have less heavily calcified and more flexible bones than adults. The 
increase of convexity at the pressure side is associated with bone resorption, whereas 
the increase of concavity at the tension side is associated with bone formation 
(Kirshnan and Davidovitch, 2006). 
 
2.1.1.2.2 Piezoelectricity  
Piezoelectricity is a phenomenon observed in many crystalline materials, in which a 
deformation of a crystal structure produces a flow of electric current (Kirshnan and 
Davidovitch, 2006).  After bone bending, the distortion of crystalline structures of 
bone generates bioelectric charges and can regulate the remodeling of alveolar bone 
during orthodontic tooth movement. Concave bone surfaces characterized by 
osteoblastic activity are electronegative; convex bone surfaces characterized by 
osteoclastic activity are electropositive or electrically neutral (Meikle, 2006). 
It should be noted that these piezoelectric signals have two unusual characteristics: (1) 
a quick decay rate and (2) the production of an equivalent signal, opposite in direction, 
when the force released, therefore the sustained orthodontic tooth movement does not 
produce prominent stress-generated signals (Proffit, 2007). 
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2.1.2 Phases of tooth movement 
There are 4 phases of tooth movement. The first phase (initial phase) lasts 24 hours to 
2 days, the cellular and tissue reactions start in this phase of tooth movement 
immediately after force application. Depending on the magnitude of applied force, the 
tooth movement stops in the second phase (lag phase) for 20 to 30 days because of the 
induced necrosis of cellular elements within the PDL at the pressure side. The 
phagocytic cells, which recruit from the adjacent marrow spaces and from the 
direction of the viable PDL, remove the necrotic tissues from compressed PDL sites 
and adjacent alveolar bone.  
After the removal of necrotic tissue (hyalinization) formed during the second phase, 
tooth movement is accelerated in the third phase (postlag phase or acceleration stage) 
and continues into the fourth phase (linear stage) (Burstone, 1962; Pilon et al., 1996; 
Van Leeuwen et al., 1999, Kirshnan and Davidovitch, 2006).  Proffit refers that heavy 
forces lead to undermining resorption while the lighter forces enable frontal resorption 
without delay (Proffit, 2007). 
It must be kept in mind that hyalinization zones at the pressure areas could form even 
during third and fourth stage, especially in areas where high forces were applied (Von 
Böhl et al., 2004). 
 
2.1.3 Optimal orthodontic force  
Schwarz defined optimal continuous force as „„the force leading to a change in tissue 
pressure that approximated the capillary vessels‟ (Schwarz, 1932). Storey and Quinn 
correlated optimal force to the surface area of the root (Storey and Smith, 1952; Quinn 
and Yoshikawa, 1985). 
Traditionally, orthodontic forces have been categorized as “light” or “heavy,” and it 
was assumed that light forces are preferable, because of their ability to evoke frontal 
resorption of bone and therefore more physiologic than heavy forces that cause 
necrosis (hyalinization) of the PDL and undermining bone resorption (Kirshnan and 
Davidovitch, 2006). Since some trauma is always associated with applied orthodontic 
forces, even light ones, and precise measurement of force applied to roots or parts 
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thereof is impossible, a current concept of optimum force was performed. This concept 
means that there is a force of certain magnitude and temporal characteristics 
(continuous versus intermitted, constant versus declining) capable of producing a 
maximal rate of tooth movement, without tissue damage, and with maximum patient 
comfort. The optimal force for tooth movement may differ for each tooth and for each 
individual patient (Ren et al., 2003). 
These orthodontic forces deform the extracellular matrix and activate cells of the 
paradental tissues in sequential cellular and molecular events that lead to convert the 
mechanical energy to biochemical and/or electrical signals. This process is known as 
mechanotransduction (Krishnan and Davidovitch, 2009). 
 
2.2 Mechanotransduction in bone and PDL 
In nearly all aspects of biology, forces are a relevant regulator of life‟s form and 
function. More recently, science has established that cells are exquisitely sensitive to 
forces of varying magnitudes and time scales, and they convert mechanical stimuli into 
a chemical response. This phenomenon, termed mechanotransduction, is an integral 
part of cellular physiology and has a profound impact on the development of the 
organism. Furthermore, mal-functioning mechanical properties or 
mechanotransduction often leads to pathological alterations of the organism (Kolahi 
and Mofrad, 2010). 
There are four essential interrelated steps in the transduction of mechanical signals by 
tissues: sensing the mechanical signal by the cells, transduction of this mechanical 
signal into biochemical one, transmission of the biochemical signal to the effector 
cells, and the effectors cell response (Wise and King, 2008).  
Mechanosensing is a process by which cells sense structural changes in the 
extracellular matrix (ECM), caused by external mechanical loading. Each cellular 
system in paradental tissues is equipped with mechanosensors; thus, each mechanical 
stimulus may activate multiple mechanosensors, followed by downstream cellular 
events (Krishnan and Davidovitch, 2009). 
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In bone, bone cells respond to fluid flow stimulation in vitro by the production of 
mediators such as nitric oxide (NO) and prostaglandins (Klein-Nulend et al., 2005). 
The signal might be transduced to the osteocytes through specific receptors or through 
deformation of the cytoskeleton (Duncan and Turner, 1995). The cell deformation may 
occur indirectly through fluid flow and/or directly through integrins (Hennemann et 
al., 2008). 
Many studies suggest that the mechanosensory molecules are: ion channels, integrins, 
G-proteins, the Wnt surface receptor and the cytoskeleton (Sawakami et al., 2006; 
Scott et al., 2008).  
Gated ion channels are involved in hearing and touch as well as maintaining osmotic 
homeostasis and regulating cell volume. In these contexts, tension created in the 
cytoskeleton in response to loading can alter the shape of the membrane lipid bilayer, 
resulting in changes in ion channel behavior (Hamill and Martinac, 2001; Jacobs et al., 
2010). There is also evidence of interplay between different channels and between 
channels and other molecular mechanosensors. For example, annexin V is a calcium 
channel that binds extracellular collagen and cytoskeletal actin. It is involved in the 
intracellular calcium response to fluid flow in osteoblasts. This suggests the possibility 
that mechanical force in the actin cytoskeleton may open this channel (Haut Donahue 
et al., 2004, Jacobs et al., 2010). 
Integrins, which are present on the cell membrane, connect the intracellular actin 
filaments through a variety of cytoskeletal linker proteins to ECM. This focal adhesion 
complex not only transduces matrix strain to the cytoskeleton but also activates protein 
kinases that initiate a variety of intracellular signalling pathways (Wang and 
Thampatty, 2006; Schwartz, 2011). There is cross-talk between integrins and growth 
factors receptors occurs at multiple levels. For example, integrin αvß3 enhances 
insulin-like growth factor-I receptor (IGF-IR) signaling through FAK-dependent 
phosphorylation of IGF-IR. Mice that lack this gene in embryonic fibroblasts showed 
impaired phosphorylation of IGF-IR in response to insulin-like growth factor-I (IGF-
I), and IGF-I-dependent cell proliferation is blocked (Liu et al., 2008; Legate et al., 
2009). 
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Guanine nucleotide–binding proteins or G-proteins are signaling GTPases that 
alternate between an active GTP-bound state and an inactive GDP-bound state. A G-
protein-coupled receptor includes a transmembrane receptor and an intracellular G-
protein, which is activated (GDP replaced with GTP) owing to a conformation change 
that occurs with ligand binding or mechanical stimulation (independent of ligand 
binding) (Chachisvilis et al., 2006; Jacobs et al., 2010). 
The Wnt surface receptor, low-density lipoprotein receptor related protein 5 (LRP5), 
has been suggested as a key regulator of bone mass. Its signaling pathway may be 
important for the osteogenic response to loading (Sawakami et al., 2006; Wise and 
King, 2008). 
The cytoskeleton represents a system of intracellular fibers and accounts for much of 
the structural integrity of the cell, incorporating microtubules, intermediate filaments 
and actin filaments. These networks are thought to maintain a constant, basal level of 
tension, so that small, local deformations affect overall cytoskeletal tension, initiating 
cellular responses (Myers et al., 2007). 
Several in vitro studies demonstrated the involvement of extracellular and intracellular 
signaling components in mechanotransduction (Liedert et al., 2005). The earliest 
experiments showed that the immediate response of cells to mechanical strain was the 
generation of prostaglandins (PGs), nitric oxide (NO), the second messenger cyclic 
adenosine monophosphate (cAMP) and inositol phosphates. Changes in intracellular 
[Ca 2+] were shown to occur via stretch-activated ion channels (Harell et al., 1977; 
Yeh and Rodan, 1984; Sandy et al., 1989; Davidson et al, 1990; Klein-Nulend et al, 
1995; McDonald et al., 1996; Meikle, 2006). Thus, the transduction of the mechanical 
signals into biochemical signals begins.  
These messengers will evoke a nuclear response which will either result in production 
of factors responsible for osteoclast recruitment and activation, or bone forming 
growth factors (Roberts-Harry and Sandy 2004). 
The downstream signalling pathways during mechanical stretching appear to overlap 
with known growth factor and hormone signals (Scott et al., 2008) (Fig. 1). 
 
17 
 
 
 
 
 
Figure 1: Schematic diagram of interactions of different signaling pathways during 
mechanical stretching. Membrane-bound receptors such as Ca
2+
 channels, integrins, 
Gproteins, IGF and TGF-b and/or BMP receptors are stimulated by mechanical forces, 
resulting in induction of several transcription factors that regulate osteoblast differentiation 
and formation. AP-1 and Runx2 are induced mainly through MAPK and SMADs pathways. 
Runx2 is also stimulated via the Wnt pathway, involving b-catenin and TCF or LEF factors. 
PLC–PKA pathway contributes to NF-kB, Cox-2 and CREB induction. Abbreviations: AP-1, 
activator protein-1; b-cat, b-catenin; DAG, diacylglycerol; FAK, focal adhesion kinase; G, G-
protein; IP3, inositol (1,4,5)-trisphosphate; MEKK, MAPK kinase kinase; PKA, protein 
kinase A; PKC, protein kinase C; PLC, phospholipase C; PYK2, proline-rich tyrosine kinase 
2 (From Papachroni et al., 2009). 
 
Discoveries in mechanobiology have illuminated sequential cellular and molecular 
events, such as synthesis and secretion of specific products (Krishnan and 
Davidovitch, 2009). One of these molecules is Insulin-like growth factors (IGFs). 
2.3 Insulin-like growth factor peptide family 
IGFs represent a family of endocrine, paracrine and autocrine polypeptides. The IGF 
family is comprised of ligands (IGF-I, IGF-II, and insulin), six well characterized 
binding proteins (IGFBP-1 though -6), and cell surface receptors that mediate the 
actions of the ligands (IGF-I receptor, insulin receptor, and the IGF-II mannose-6-
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phosphate [(M-6-P) receptor] (LE Roith et al., 2001; Lelbach et al., 2005; Annunziata 
et al., 2001) (Fig. 2).    
 
 
Figure 2: The IGF family and related signaling molecules. Ligands, cell-surface receptors, 
and the IGF-binding proteins (IGFBPs) constituting the IGF system are shown. Molecules 
binding IGF with low affinity, including IGFBP-related proteins (IGFBP-rPs) and IGFBP 
fragments generated by IGFBP protease cleavage, are also indicated. IGF-1 interacts with 
IGF1R and IGFBPs, IGF-2 interacts with IGF1R, IGF2R, IR and IGFBPs, in particular 
IGFBP- 5 and -6. Insulin interacts with IR. Some IGFBPs, IGFBP-3 and –5 in particular, 
may exert their effects via their own receptor independently of their capacity to modulate IGF 
signaling through IGF1R or IR (from Dupont and Holznberger, 2003). 
 
2.3.2 Insulin-like growth factors 
IGF-I is a trophic factor that circulates at high levels in the blood stream. Although the 
main source of IGF-I in the serum is liver, many other tissues synthesize it and are 
sensitive to its action, especially during postnatal development. Regulation of hepatic 
IGF-I production is mostly mediated by growth hormone (GH) and insulin. In turn, 
IGF-I feeds back to suppress growth hormone and insulin release (Pavelic et al., 2007). 
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The synthesis of IGF-I is controlled by a number of endogenous (genetic and 
hormonal) and exogenous (nutrition and physical activity) factors. About one-third to 
one-quarter of IGF-I expression is determined by exogenous factors (Zofkova, 2003). 
The synthesis of IGF-II is relatively GH-independent. Its expression is much higher 
during fetal development than in postnatal life. It acts as a regulatory peptide; it is 
mitogenic for a number of cell types (Pavelic et al., 2007). 
IGF-I and IGF-II are single-chain polypeptides, with sequences 62 % identical to that 
of proinsulin. However, unlike insulin and other peptide hormones, they are not 
produced and stored within the cells of a specific tissue, but may instead be produced 
by almost any cell in the body (Dupont and Holzenberger 2003). 
The ligands IGF-I and IGF-II are involved in various cellular processes including 
differentiation, proliferation, morphogenesis, growth, apoptosis, control of metabolic 
function and carcinogenesis (Clemmons AND Maile 2005; Danley et al., 2005). 
 
2.3.3 Insulin-like growth factor receptors 
Most of the cellular effects of the IGFs are mediated by binding to the IGF-IR. The 
IGF-IR is a transmembrane tyrosine kinase structurally similar to the insulin receptor. 
It is composed of two extracellular α-subunits and two intracellular β-subunits (Laron, 
2001). The α-subunits bind IGF-IR to IGF-I, IGF-II and insulin at supraphysiological 
concentration, while the β-subunits transmit the ligand-induced signals (Jones and 
Clemmons, 1995; Mauro and Surmacz, 2004). Binding of the ligands to the IGF-IR 
induces its autophosphorylation via tyrosine kinase activity. This, in turn, causes the 
interaction with certain cellular substrates such as insulin receptor substrate 1 (IRS1), 
adapter protein Shc and 14-3-3-proteins (Romano, 2003; Laviola et al., 2007).  
A major intracellular substrate for the IGF-IR is IRS1 which, after its tyrosine 
phosphorylation, initiates multiple signallings. It mediates the transmission of 
mitogenic, metabolic and antiapoptotic signals (Jones and Clemmons, 1995; Ogata et 
al., 2000). 
IGF-II receptor is a single large transmembrane receptor which bind with IGF-II and, 
with a much lower affinity, with IGF-I. The IGF-II receptor does not appear to act as a 
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traditional signaling receptor in response to IGF binding and is thought to act mainly 
as a clearance receptor for IGF-II (Holly and Perks, 2006; Samani et al., 2007). 
 
2.3.4 IGF binding proteins and proteases 
IGFBPs are a family of secreted proteins that bind IGF with high affinities that are 
greater than those of the IGF-IR. Six distinct IGFBPs, designated as IGFBP-1 to -6, 
have been isolated and characterized from human and a variety of vertebrate species 
(Firth and Baxter, 2002; Kelley et al., 2002). 
IGFBPs function as carrier proteins for circulating IGFs and serve not only as a 
reservoir for IGFs release, but also greatly increases the half-life of IGFs, and regulate 
IGF turnover, transport of IGFs from the vascular space to target tissues, and tissue 
distribution. IGFBPs expressed in many peripheral tissues. They have been shown to 
inhibit or potentiate IGF actions in vitro.  While IGFBP-4 and IGFBP-6 have been 
consistently found to inhibit IGF actions, IGFBP-1, -2, -3, and -5 can both inhibit and 
potentiate IGF actions, depending on cell type (Duan and Xu, 2005).  
There is compelling evidence that some IGFBPs possess biological activities that are 
ligand-independent. These include growth inhibition, direct induction of apoptosis, and 
modulation of the effects of other non-IGF growth factors (Firth and Baxter, 2002; 
Mohan and Baylink, 2002). For example, IGFBP-3 inhibits cell growth in the absence 
of IGFs and in IGF-1R-null cells (Butt and Williams, 2001). 
IGF-BP degrading proteases act as growth stimulators by increasing local IGF 
availability. They fall into three major categories. Kallikrein-like serine proteases, the 
second major category is cathepsins and intracellular proteinases, and the third 
category involves matrix metalloproteinases. Proteolytic activity by proteases may 
play a role in normal and abnormal tissue proliferation by cleaving IGF-BP into 
fragments with lower affinity for IGFs, thereby increasing the levels of free IGFs to 
activate IGF-IR (Cohen, 2006). These proteases are under the control of autocrine, 
paracrine, and hormonal influences (Rosen, 1999).  
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2.3.5 The role of IGFs in bone and oral biology 
In bone, many factors regulate homeostasis. IGF-I and IGFII are the most abundant 
growth factors stored in bone and are locally produced by bone cells. IGFs increase 
bone formation by regulating proliferation, differentiation, and apoptosis of osteoblasts 
(Govoni et al., 2005).  
Consistent with this role, patients with Laron syndrome, caused by IGF-I deficiency, 
present marked osteoporosis (Laron et al., 1998). 
Genetic modifications in specific components of the IGF system have provided 
tremendous insights into the role of the IGFs and IGF-IR in vivo. For example, the 
overproduction of IGF-I in the osteoblasts of transgenic mice increases bone formation 
(Zhao et al., 2000), whereas the overproduction and deficiency of IGF-II in mice has 
no major effect on skeletal size or bone turnover in mice (DeChiara et al., 1991; Wolf 
et al., 1995). In addition, mice lacking IGF1R display marked organ hypoplasia and 
delayed skeletal ossification (Yakar and Rosen, 2003) 
The IGFs fulfills an important role in growth and development of teeth, mandible, 
maxillae, and tongue. It has been postulated that IGF-I may be of great value in the 
treatment of periodontal defects and in tissue healing (Werner and Katz, 2004).  
The suitability of IGF-I, in combination with other growth factors, for periodontal 
regeneration has been tested (Palioto et al., 2004, Sant'Ana et al., 2007).  
It is believed, that IGFs behave as poliferative factors for cementoblasts (Grzesik and 
Narayanan, 2002). They are involved in early root formation by regulating the mitotic 
activity of the outer layer of the epithelial cells of Hertwig's root sheath (Fujiwara et 
al., 2005). 
Recently, the distribution pattern of IGFs components was investigated in both 
deciduous and permanent teeth. Many of them were found to be localized in the 
periodontium of human and rats (Götz et al., 2001; 2003; 2006a). 
2.3.6 IGF-I and mechanical loading 
Mechanical loading has been demonstrated to be an important regulatory factor in 
alveolar bone homeostasis. It plays an essential role in maintaining the structure and 
mass of the alveolar processes throughout life (Pavlin and Gluhak-Heinrich, 2001).  
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On the other hand, skeletal unloading reduces proliferation and differentiation of 
osteoprogenitor cells in vitro (Kostenuik et al., 1997). 
In vitro studies showed also that mechanical load increases the level of IGF-I in 
osteoblasts (McCarthy and Centrella, 2001).  In addition, gene expression of IGF-I is 
detected during distraction osteogenesis and fracture healing (Bouletreau et al., 2002). 
In a recent study, it was demonstrated that IGF-I mRNA is twofold up-regulated in 
osteocytes of cortical bone after 6 h of mechanical loading, and thus supported the 
hypothesis that osteocytes are most important cells for the translation of mechanical 
stimuli into bone formation via IGF-I (Reijnders et al., 2007). 
 
3. Aims and hypotheses 
 
In this study should be investigated:  
1. whether the locally produced IGF-I participate in the mechanotransduction process 
in the PDL during the early phase of tooth movement, 
2. whether there is a differentiated expression pattern of IGF-I, IGF-IR and IRS1 in 
pressure and tensile sides, 
3. and whether the distribution of IGF-I are dependent on the magnitude of the applied 
forces. 
Moreover, the possible role of IGF-I in the remodeling of PDL during the early phase 
of orthodontic tooth movement should be also discussed. 
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4. Materials and methods 
4.1 Animals 
Twelve-week-old male Wistar rats each weighing 300–350 g (Harlan Winkelmann, 
Borchen, Germany) were used as experimental animals. The animal use protocol was 
reviewed and approved by the Institutional Animal Care and Use Committee of the 
local district government (Cologne) and the Animal Care Commissioner of the 
University of Bonn (Germany). 
 
4.2 Experimental procedure 
According to the experimental protocol of Kawarizadeh et al. (2004), rats were 
anaesthetized with 0.01 ml Rompun (Bayer, Leverkusen, Germany) and 0.24 ml 
Ketavet (Pharmacia and Upjohn, Erlangen, Germany). The animals were clamped into 
a head-holding device, and the occlusal surface of the maxillary right first molar was 
prepared by grinding a small hole with a dental diamond bur. The tooth surface was 
then treated with self-etching bonding material (Xeno III, Dentsply DeTrey, Konstanz, 
Germany) for 60 s. An orthodontic appliance consisting of a T-loop (0.016 _ 0.022-in. 
stainless steel wire, Ormco Corp., Glendora, CA, USA) was placed between the molar 
and a high-resolution 3D force/torque transducer (ATI, Industrial Automation, Garner, 
NC, USA), which had a resolution of 0.0125 N for force and 0.0625 Nmm for torque. 
The T-loop was fixed to the occlusal surface of the molar with light-curing composite 
(Tetric, Vivadent, Schaan, Liechtenstein) (Fig. 3, 4, 5).  
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Figure 3: Experimental procedure for the application of the orthodontic force system. The 
rats were clamped onto a head holding device, in order to place an orthodontic appliance 
consisting of a T-loop.  
 
 
Figure 4: Placement of the appliance in the oral cavity of the rat.  
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Figure 5: Experimental set up: Diagrammatic representation of the experimental procedure 
for the application of the orthodontic force system. The force system was applied and 
measured by a 3D force/torque transducer, and mounted onto a 6-axis-positioning table. By 
moving the transducer, we applied loads to the first molar.  
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In the first group of animals, constant forces for 4 hours of 0.1 N, 0.25 N and 0.5 N 
were applied in four animals each in order to move the molars mesially. The applied 
forces were kept constant and recorded continuously for 4 h (Fig. 6).  
 
 
 
 
 
Figure 6: Presentation of a typical load-diagram: The force curves measured in the x-
direction indicate a constant loading of the rat molar; these were approximately 0.1 N, 0.25 N 
and 0.5 N. The forces in the other directions were close to zero. 
 
In the second group, constant forces of 0.1 N were applied for 2 hours in 8 animals. 
Afterwards, the first and second molars were passively separated with composite and 
the occlusal contacts were eliminated by slicing the antagonistic lower molars. Four 
rats were killed after 1 day and four after 2 days. The untreated contralateral molars in 
4 rats served as controls. 
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4.3 Histology 
The anaesthetized animals were killed by an intravenous application of 2 ml T61 
(embutramide mebezonium iodide; Intervet, Unterschleissheim, Germany) and 
decapitated. The maxillae were removed and dissected into right and left halves. 
The soft tissues around the jawbone, except for the gingiva, were removed. The 
specimens were fixed in 4 % paraformaldehyde in 0.1 M phosphate buffer for 24 h and 
decalcified in 10 % ethylene diamine tetraacetic acid (EDTA) at room temperature for 
5 weeks. After being dehydrated in ascending grades of ethanol, cleared in xylene, and 
paraffin-embedded, specimens were cut parasagittally with a microtome into 5-mm 
serial sections (HM 355s; Microm Int., Walldorf, Germany) and mounted on glass 
slides (K. Roth, Karlsruhe, Germany). Selected sections were stained with 
haematoxylin–eosin. 
 
4.4 Immunohistochemistry 
To establish representative regions of the periodontium and the adjacent alveolar bone, 
those sections were chosen that showed the medial root of the right upper first molar in 
maximal length. From these, three sections were taken at 30-mm intervals for 
quantitative analysis. Immunohistochemical staining was carried out with anti-IGF-I 
mouse monoclonal antibody (diluted 1:100, Biomol, Hamburg, Germany), polyclonal 
chicken anti- IGF-IR (diluted at 1:25, Biomol, Hamburg, Germany), and monoclonal 
mouse anti-IRS1 (diluted 1:300, Santa Cruz, Santa Cruz, USA). The sections were 
deparaffinized and rehydrated, rinsed with tris-hydroxymethyl aminomethane-buffered 
saline solution (TBS) at pH 7.4 for 10 min, and then soaked in methanol/H2O2 for 10 
min in the dark, to block endogenous peroxidase activity.  
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In details the sections were treated with the following sequence:  
1. xylol                                                10 min.  
 
2. xylol                                                10 min.  
 
3. 100 % ethanol                                  5 min.  
 
4. 100 % ethanol                                  5 min  
 
5. 90 % ethanol                                    5 min  
 
6. 70 % ethanol                                    5 min  
 
7. aqua dest                                          5 min  
 
8. TBS                                                 10 min  
 
9. methanol/H2O2                               20 min 
 
Sections for IRS1 immunostaining were pretreated with goat serum (DAKO, Glostrup, 
Denmark) for 90 minutes. Antibodies were diluted in 1 % bovine serum albumin. The 
IGF-I antibody was applied in a humidity chamber for 1 hour at room temperature, the 
IGF-IR-and IRS1 antibodies overnight at 4 °C. Subsequently, sections were washed in 
TBS and incubated with suitable Envision+/HRP anti-mouse for IGF-I, anti-rabbit for 
IRS1 (Dako Cytomation, Hamburg, Germany) or anti-chicken for IGFIR (Rockland, 
Gilbersville, USA) diluted in 1 % TBS–BSA at 1:450, as secondary antibodies for 30 
minutes in a humidity chamber at room temperature. 
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Antibody complexes were visualized using diaminobenzidine (DAB) for 10 minutes 
which yields a brown staining product. Thereafter, slides were rinsed, counterstained 
with Mayer‟s haematoxylin for 5 seconds, rinsed again, and mounted.  
 
10. Goat serum only for IRS1-sections                                                90 min 
11. Primary antibodies:                                
                                                                          Dilution                      
  Monoclonal mouse anti-IGF-I                         1:100                         1Hour 
  Polyclonal chicken anti- IGF-IR                      1:25                          overnight 
  Monoclonal mouse anti-IRS1                          1:300                         overnight 
12. TBS                                                                                                10 min 
           
                                                                                    
13. Secondary antibodies:                                                                                                                
Envision+/HRP anti-mouse                                                                30 min                                                                  
Anti-goat immune globulin/HRP                                                        30 min 
Anti-chicken for IGFIR                                    1:450                         30 min 
14. TBS                                                                                               10 min  
15. Diaminobenzidine (DAB)                                                             10 min 
16. TBS                                                                                               10 min 
17. Mayer‟s hematoxylin                                                                     1 sec 
18. 100 % ethanol                                                                                2 min 
19. 100 % ethanol                                                                                2 min 
20. xylol                                                                                               2 min  
21. xylol                                                                                               2 min 
Negative controls were prepared by omission of the primary antibodies from the 
staining procedures and replacing it with an isotype IgG using the identical 
concentration.  
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4.5 Histomorphometry and statistical analysis 
Sections were scanned by means of a scanner camera (Axio Cam MRC; Zeiss, 
Göttingen, Germany) mounted on a light microscope (Axiophot 2; Zeiss, Göttingen, 
Germany), and viewed with imaging software (Axiovision; Zeiss, Göttingen, 
Germany) on a personal computer. Counting of the percentage of immuno-
histochemically positive cells was performed in two separate predefined areas in every 
selected section. These areas were located mesio-coronally and disto-coronally to the 
medial root. Counts were made at a magnification of 400. 
Means and standard deviations were calculated for each group of four rats. Hundred 
sections were randomly selected from the original samples and remeasured by the 
same operator after a time interval of 3 months without reference to the previous 
measurements.  
The casual error was calculated according to Dahlberg‟s formula: 
 
 
 
Where Sx is the error of the measurement, D is the difference between duplicated 
measurements, and N is the number of double measurements. 
The percentage of IGF-I-, IGF-IR- and IRS1-positive cells was calculated with Excel 
software. The statistical analyses were performed with SPSS Software, version 17 
(SPSS Inc. Chicago, IL). The normality test was used to estimate the normal 
distribution of the data. The percentage of positive cells for all tested factors was 
compared using post hoc test (Bonferroni). The level of statistical significance was set 
at p < 0.05. 
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4.6 The used chemicals, reactors and instruments 
 
4.6.1 List of the chemicals:  
Acetone                                                              Otto Fischer, Saarbrücken, Germany  
Ethanol (70-100 %)                                            Merck, Münster, Germany  
Embedding medium DePex                               Serra, Heidelberg, Germany  
3,3-diaminobenzidin(DAB)                               Sigma, Steinheim, Germany  
Ethylene diamine tetraacetic  
acid (EDTA)                                                      Calbiochem, Darmstadt, germany  
Eosin solution 1 %                                             Merck, Darmstadt, Germany  
Formic acid                                                        Merck, Darmstadt, Germany  
Formaldehyde 40 %                                          Merck, Darmstadt, Germany  
Hematoxylin                                                      Merck, Darmstadt, Germany  
Methanol                                                            Merck, Darmstadt, Germany  
Sodium chloride                                                 Merck, Darmstadt, Germany  
Sodiumsulfate solution                                      Merck, Darmstadt, Germany  
Paraffin-Histo-comp                                          Vogel, Giessen, Germany  
Hydrochloride 2 mol/l                                       Merck, Darmstadt, Germany  
Serumalbumin from bovine                               Paesel and Lor, Frankfurt, Germany  
Tris                                                                     ICN Biomedicals, Ohio, USA  
Xylol original                                                     Merck, Darmstadt, Germany  
Xylol substitute XEM-200                                 Vogel, Giessen, Germany 
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4.6.2 List of the reactors:  
TBS-solution:  
-9.0 gr NaCl  
-6.0 gr Tris  
-1000 ml aqua dest. + 2 ml HCl pH 7.6  
TBS-BSA-solution:  
-0.1 gr serumalbumin from bovine  
-10 ml TBS-solution  
EDTA:  
-200 gr EDTA  
-68 gr Tris  
-2000 ml aqua dest 
 
4.6.3 List of the instruments:  
Analysis scale                                     Sartorius, Göttingen, Germany  
Thermo cupboard                                Memmert, Schwabach, Germany  
Cover glass                                          Engelbrecht, Edermunde, Germany  
DigitalpH-meter 197                           WTW, Vienna, Austria  
Eppendorf pipettes                              Eppendorf, Hamburg, Germany  
Light microscope Axioskop 2            Zeiss, Göttingen, Germany  
Axio Cam MRC                                  Zeiss, Göttingen, Germany  
Rotation microtome HM 3559           Microtom, Walldorf, Germany  
Superfrost plus slides                          Menzel, Braunschweig, Germany  
Warm plate                                          Medax Nagel, Kiel, Germany 
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5. Results 
 
5.1 Histology 
Orthodontic loading resulted in stretching of the periodontal fibres on the disto-coronal 
aspects of the medial root and compression of the ligament on the mesio-coronal 
aspects of the medial root (Fig. 7). 
In the first group, where constant forces for 4 hours of 0.1 N, 0.25 N and 0.5 N were 
applied in four animals each, tension and compression sides looked almost the same 
because of the shortness of the experiment. 
On the tension side, especially those teeth to which a high force (0.5 N) had been 
applied showed obvious structural disturbance of PDL fibres and some sections howed 
pyknosis of PDL cells (Fig. 17B). In the teeth for which lower forces had been used, 
this phenomenon was less obvious. In the second group, in which the rats were killed 
after 1day and 2 days from application of constant forces for 2 hours, the mesial side 
of PDL was compressed and the distal PDL widened. 
 
 
 
Figure 7: (A, B) Overview: Experimentally loaded right first molar (B) and untreated 
contralateral molar (A). Arrow indicates the force direction. HE staining; magnification 50x;  
AB, alveolar bone; PDL, periodontal ligament; Ce, cementum; D, dentin; P, pulp; Mr, medial 
root; Gt, gingival tissue; Mc, mesial coronal; Dc, distal coronal. 
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Figures 15A and 19A show blood vessels in various sizes in the sections of PDL.  
Osteoclasts were seen on the alveolar bone surface in the disto-coronal areas of 
untreated rats (Fig. 10A, 19A), after 24 and 48 hrs from force application, no more 
osteoclasts were found. 
The total number of PDL cells in the tension side increased significantly compared 
with the control group especially after 24 hrs and decreased significantly in the 
pressure side (Fig. 8).  
 
 
 
Figure 8: Total numbers of the PDL-cells, expressed as pillars, dark-coloured pillars 
represent mesio-coronal areas and light-coloured ones represent disto-coronal areas. The 
results are expressed as means and standard deviations. Symbols indicate the significant 
difference (p < 0.05) between experimental groups and the control group () or among 
marked groups and the other groups (). 
 
 
 
 
35 
 
 
 
 
5.2 Immunohistochemistry and Histomorphometry 
In the control group, immunoreactivity for all investigated proteins was distributed 
throughout the examined PDL-areas, but tended to be localized more on the mesial 
side (12A, 17A, 21A) than on the distal side of the medial root (10A, 15A, 19A). 
Immunoreactivity was observable in osteoblasts, fibroblasts, osteoclasts and 
cementoblasts. According to Dahlberg‟s formula, the casual error was 3.65. The 
unwanted background staining, which is one of the most common problems in 
immunohistochemistry, was reduced by blocking the endogenous peroxidase activity 
for 10 min with H2O2. As expected, no immunostaining appeared under the negative 
control conditions (Fig. 9). 
 
  
5.2.1 Results for IGF-I  
As a reaction to load, changes in immunoreactivity were seen for all proteins examined 
on both the mesial and distal sides of the PDL. The number of IGF-I positive PDL 
cells on the tension side (disto-coronal) was found to be significantly increased in the 
both groups in comparison with the controls (Fig. 10, 11, 14). The differences between 
Figure 9: negative control for IGF-I. 
Magnification 400x; AB, alveolar 
bone; PDL, periodontal ligament; 
Ce, cementum. 
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the groups, where constant forces for 4 hrs of 0.25 N and 0.5 N were applied, and the 
group, where the rats were killed after 48 hrs, were significantly recognized. In the 
pressure side (mesio-coronal), the number of IGF-I-positive cells was significantly 
decreased in the 4 hrs group (Fig. 12, 13A, 14). This decrease tended to be dependent 
on the force magnitude. After 24 and 48 hrs the number of the immunopositive cells 
increased to the mean level of the control group in the mesio-coronal areas. Thus, the 
differences between the first and second group were significant with one exception. 
No significant difference was seen between the group, where 0.1N were applied for 4 
hrs, and the 24 hrs group (Fig. 13B). 
 
Figure 10: (A, B) Representative views of immunolabelling for IGF-I on the disto-coronal 
aspects in the PDL of the medial root. The immunolabelling of IGF-I represented in control 
tooth (A) and in tooth treated with force of 0.1N for 4hrs (B). The immunostained cells appear 
brown (arrows). The labelled cells are regularly distributed in the periodontal ligament. DAB 
staining; magnification 400 x; AB, alveolar bone; PDL, periodontal ligament; Ce, cementum; 
Oc, osteoclast; arrows, immunopositive cells.   
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Figure 11: (A, B) Representative views of immunolabelling for IGF-I on the disto-coronal 
(tension side) aspects in the PDL of the medial root. The immunolabelling of IGF-I was 
represented in teeth treated with the mentioned loading regimes for 24 hrs (A) and 48 hrs (B). 
The immunostained cells appear brown (arrows). The labelled cells are regularly distributed 
in the periodontal ligament. DAB staining; magnification 400 x; AB, alveolar bone; PDL, 
periodontal ligament; Ce, cementum; arrows, immunopositive cells. 
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Figure 12: (A, B) Representative views of immunolabelling for IGF-I on the mesio-coronal 
aspects in the PDL of the medial root. The immunolabelling of IGF-I was represented in 
control tooth (A) and in tooth treated with force of 0.1N for 4hrs (B). The immunostained cells 
appear brown (arrows). The labelled cells are regularly distributed in the periodontal 
ligament of the control tooth and significantly reduced in the periodontal ligament of the 
treated tooth. DAB staining; magnification 400 x; AB, alveolar bone; PDL, periodontal 
ligament; Ce, cementum; arrows, immunopositive cells.  
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Figure 13: (A, B) Representative views for immunolabelling of IGF-I on the mesio-coronal 
(pressure side) aspects in the PDL of the medial root. The immunolabelling of IGF-I was 
represented in teeth treated with forces of 0.1N for 4hrs (A) and with the mentioned loading 
regimes for 48 hrs (B). The immunostained cells appear brown (arrows). The labelled cells 
are regularly distributed in the periodontal ligament. DAB staining; magnification 400 x; AB, 
alveolar bone; PDL, periodontal ligament; Ce, cementum; arrows, immunopositive cells. 
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Figure 14: Percentage of the numbers of the IGF-I-positive cell. They are expressed as 
pillars, the dark-coloured pillars represent the mesio-coronal areas and the light-coloured 
ones represent the disto-coronal areas. Each pillar represents a group of four animals treated 
with the mentioned loading regimes. The immunopositive cells were counted as percentages of 
the total number of cells. Results are representative of 3 sections of each animal. For each of 
the 4 specimens, a total of 2 fields in 3 sections were analyzed. The results are expressed as 
means and standard deviations. The symbol () indicates a significant difference (p < 0.05) 
between experimental groups and the control group. 
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5.2.2 Results for IGF-IR 
 
As seen by IGF-I, the number of immunopositive cells of IGF-IR on the tension side 
(disto-coronal) was found to be significantly increased in the both groups in 
comparison with the controls (Fig. 15, 16, 18). This increase of the immunopositive 
cells in 4 hrs groups was negative dependent on the force magnitude. The difference 
between groups, where forces of 0.1 N and 0.5 N for 4 hrs were applied, was 
significant. After 24 hrs, the IGF-IR-positive cells reached their peak point and tend to 
decrease slightly after 48hrs. Significant differences between the groups, where 
constant forces for 4 hours of 0.25 N and 0.5 N were applied, and the 48 hrs group 
were observed. 
At the pressure side (mesio-coronal), the significant effect of the force application on 
the number of IGF-IR-positive cells was not dependent on experimental time but on 
the force magnitude. The number of IGF-IR-positive cells was significantly decreased 
in groups treated with forces of 0.25N and 0.5N, whereas the group treated with light 
force of 0.1N showed no significant differences compared to control group in the 
mesio-coronal areas (Fig. 17, 18). Therefore, the differences between the groups, 
where 0.5N for 4 hrs was applied, and the second group (24 hrs and 48 hrs) were also 
significant. 
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Figure 15:  (A, B) Representative views for immunolabelling of IGF-IR on the disto-coronal 
aspects in the PDL of the medial root. The immunolabelling of IGF-I was represented in 
control tooth (A) and in tooth treated with force of 0.1N for 4hrs (B). The immunostained cells 
appear brown (arrows). The labelled cells are regularly distributed in the periodontal 
ligament. DAB staining; magnification 400 x; AB, alveolar bone; PDL, periodontal ligament; 
Ce, cementum; BV, blood vessel; arrows, immunopositive cells. 
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Figure 16: (A, B) Representative views for immunolabelling of IGF-IR on the disto-coronal 
(tension side) aspects in the PDL of the medial root. The immunolabelling of IGF-I was 
represented in teeth treated with the mentioned loading regimes for 24 hrs (A) and 48 hrs (B). 
The immunostained cells appear brown (arrows). The labelled cells are regularly distributed 
in the periodontal ligament. DAB staining; magnification 400 x; AB, alveolar bone; PDL, 
periodontal ligament; Ce, cementum; arrows, immunopositive cells. 
 
 
 
 
 
44 
 
 
 
 
 
 
Figure 17: (A, B, C) Representative views for immunolabelling of IGF-IR on the mesio-
coronal (pressure side) aspects in the PDL of the medial root. The immunolabelling of IGF-IR 
was represented in control tooth (A), in teeth treated with forces of 0.5N for 4hrs (B) and with 
the mentioned loading regimes for 48 hrs (B). The immunostained cells appear brown 
(arrows). The labelled cells are regularly distributed in the periodontal ligament. DAB 
staining; magnification 400 x; AB, alveolar bone; PDL, periodontal ligament; Ce, cementum; 
arrows, immunopositive cells. 
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Figure 18: Percentage of numbers of IGF-IR-positive cells. They are expressed as pillars, the 
dark-coloured pillars represent the mesio-coronal areas and the light-coloured ones represent 
the disto-coronal areas. Each pillar represents a group of four animals treated with the 
mentioned loading regimes. The immunopositive cells were counted as percentages of the 
total number of cells. Results are representative of 3 sections of each animal. For each of the 
4 specimens, a total of 2 fields in 3 sections were analyzed. The results are expressed as 
means and standard deviations. The symbol () indicates a significant difference (p < 0.05) 
between experimental groups and the control group. 
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5.2.3 Results for IRS1  
 
As seen by IGF-I and IGF-IR, the number of immunopositive cells of IRS on the 
tension side (disto-coronal) was found to be significantly increased in the both groups 
in comparison with the controls (Fig. 19, 20, 22). 
In the 24 hrs group, the IRS1-positive cells reached their peak point and decreased 
then significantly in the 48 hrs group. Significant differences between the first group, 
where constant forces for 4 hours of 0.1N, 0.25 N and 0.5N were applied, and the 24 
hrs group, were found. Additionally, the difference between the group, where 0.5N 
force for 4 hrs was applied, and 48 hrs group, was also significant. 
In the pressure side (mesio-coronal), the number of IRS1-positive cells decreased 
significantly in the 4 hrs group. Thereafter, the number of the positive cells increased 
in the second group to the mean level of the control group in the mesio-coronal areas. 
Therefore, the differences between the first group (4hrs) and second Group (24 and 48 
hrs) were significant (Fig. 21, 22). 
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Figure 19:  (A, B) Representative views for immunolabelling of IRS1 on the disto-coronal 
aspects in the PDL of the medial root. The immunolabelling of IRS1 was represented in 
control tooth (A) and in tooth treated with force of 0.1N for 4hrs (B). The immunostained cells 
appear brown (arrows). The labelled cells are regularly distributed in the periodontal 
ligament. DAB staining; magnification 400 x; AB, alveolar bone; PDL, periodontal ligament; 
Ce, cementum; BV, blood vessel; Oc, osteoclast; arrows, immunopositive cells. 
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Figure 20: (A, B) Representative views for immunolabelling of IRS1 on the disto-coronal 
(tension side) aspects in the PDL of the medial root. The immunolabelling of IRS1 was 
represented in teeth treated with the mentioned loading regimes for 24 hrs (A) and 48 hrs (B). 
The immunostained cells appear brown (arrows). The labelled cells are regularly distributed 
in the periodontal ligament. DAB staining; magnification 400 x; AB, alveolar bone; PDL, 
periodontal ligament; Ce, cementum; arrows, immunopositive cells. 
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Figure 21: (A, B, C) Representative views for immunolabelling of IRS1 on the mesio-coronal 
(pressure side) aspects in the PDL of the medial root. The immunolabelling of IRS1 was 
represented in control tooth (A), in teeth treated with forces of 0.5N for 4hrs (B) and with the 
mentioned loading regimes for 48 hrs (B). The immunostained cells appear brown (arrows). 
The labelled cells are regularly distributed in the periodontal ligament. DAB staining; 
magnification 400 x; AB, alveolar bone; PDL, periodontal ligament; Ce, cementum; arrows, 
immunopositive cells. 
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Figure 22: Percentage of numbers of IRS1-positive cells. They are expressed as pillars, the 
dark-coloured pillars represent the mesio-coronal areas and the light-coloured ones represent 
the disto-coronal areas. Each pillar represents a group of four animals treated with the 
mentioned loading regimes. The immunopositive cells were counted as percentages of the 
total number of cells. Results are representative of 3 sections of each animal. For each of the 
4 specimens, a total of 2 fields in 3 sections were analyzed. The results are expressed as 
means and standard deviations. The symbol () indicates a significant difference (p < 0.05) 
between experimental groups and the control group. 
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6. Discussion 
The present study was performed to investigate the occurrence and distribution of 
insulin-like growth factor-I (IGF-I), IGF-IR and IRS1 in the periodontal ligament 
(PDL) during the early stage of orthodontic tooth movement. The study was carried 
out   using forces of varying amount and different time periods in an animal model.  
This study showed that IGF-I, IGF-IR and IRS1were distributed locally in the 
control group throughout the PDL and tended to be localized more on the mesial side 
than the distal side of the medial root.   
In the PDL of human deciduous and permanent teeth as well as in the PDL of rats, 
Götz et al. have studied the occurrence of the IGFs (Götz et al., 2001; 2006a; 2006 b). 
They found that the PDL, in particular, contains mostly all IGF components.  
They have suggested that IGFs might be stored in the PDL matrix via their binding 
proteins linked to glycosaminoglycans and regulate through autocrine and paracrine 
pathways the PDL cell survival, proliferation and matrix turnover. 
Although the liver is the main source of IGF-I and the absence in its gene causes 
growth retardation in mice and humans, many cell types produce and respond to IGF-I 
via autocrine or paracrine actions (Woods et al., 1996, Bonapace et al., 2003; Barton 
and Crowder, 2010; Netchine et al, 2011). For example, IGF-I is one of the best 
characterized and the most abundant growth factors in the bone tissue (Mohan and 
baylink, 1991; Canalis, 2009). This local production of IGF-I can even compensate the 
lack of the liver IGF-I in genetically manipulated mice (andrew et al., 2001), 
suggesting that autocrine/paracrine-produced IGF-I is the main determinate of 
postnatal body growth (Ohlsson et al., 2000). 
The previous investigations and the results of this study strength the crucial role of 
autocrine and paracrine IGF-I and its impacts in the biology of PDL. 
This study elucidates that the application of precise short term loading at teeth 
in rats leads to an increase in IGF-I, IGF-IR and IRS1 expression at the tension side. 
This observation is in accordance with other studies which showed that loading at 
different tissues increases the production of IGF-I: Human movement occurs from the 
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force created by contracting muscles, which is transmitted to bone via tendon, all these 
three tissues can respond to the mechanical loading by producing local IGF-I or its 
isoform.  
In skeletal muscles, insulin-like growth factor I (IGF-I) play a critical role in their 
formation, maintenance, and regeneration. Longitudinal exercise studies have shown 
that it is possible to increase muscle strength and performance without concomitant 
and robust changes in circulating IGF-I. Such studies indicating that the effect of 
exercise on skeletal muscles is mediated via paracrine/autocrine IGF-I rather than 
endocrine IGF-I (Frystyk, 2010). Goldspink (Goldspink, 1999) showed that loading 
increases the production of IGF-I in muscle cells, functioning in an autocrine/paracrine 
mode, is an important mediator of skeletal muscle adaptation being sensitive to 
increases in loading (Adams, 2002). 
In human tendon, which resembles the PDL in its function, it can be demonstrated that 
an increase in the interstitial concentration of IGF-I and its binding proteins takes 
place after exercise. The increase in IGF-I expression in tendon includes the isoform 
that has so far been thought only to exist in skeletal muscle (mechano-growth factor) 
(Kjaer et al., 2009). In rats, it was suggested that the IGF-I and its splice variant 
mechano-growth factor (MGF) could be involved in collagen synthesis in tendon in 
response to mechanical loading (Olesen et al., 2006). 
The transmitted mechanical stimulation to bone leads to increased bone formation and 
plays an essential role in maintaining skeletal integrity. Growth factors and osteocytes, 
which act as mechanosensors, play a key role during the bone formation after 
mechanical stimulation. Recently, Reijnders et al. (2007) have found that IGF-I mRNA 
is upregulated within endocortical osteocytes of the shaft of rat tibia 6 h after 
mechanical loading. They suggested that IGF-I, which is located in osteocytes, is 
involved in the translation of mechanical stimuli into bone formation. It has been also 
demonstrated that rat osteoblasts respond to the mechanical forces which may regulate 
their activities indirectly by promoting the autocrine effect of IGF-1 (Xian et al., 
2007). 
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The ability of IGF-I to translate the mechanical stimuli into bone formation was 
investigated and verified in many experimental and clinical studies.  
Distraction osteogenesis is currently a standard method of bone lengthening (Choi et 
al., 2002). In distraction osteogenesis studies, gene expression of IGF-I was detected 
during distraction (Farhadieh et al., 1999; Yates et al., 2002). 
The application of tensile forces to the mid sagittal cranial suture during the growth 
period cause an increase in the production of IGF-I mRNA and IGF-IR mRNA in 
osteoblast-like and fibroblastic cells (Hirukaw et al., 2005). 
Hajjar et al. (2002) observed that the expression of IGFs increases in condylar 
cartilage in response to application of propulsive appliances. 
In orthodontics, Wescott et al. have applied a 12 % uni-axial cyclic tensile strain to 
cultured human PDL cells and analyzed the differential expression of 78 genes, 19 
genes, including IGF-I, show differential expression. The treated/control (T/C) ratio of 
IGF-I after 12 hrs was greater than of ± 2 (2.46) but not significant (Wescott et al., 
2007). Rath-Deschner et al. have found that IGF-I expression is significantly 
increased, when cells were subjected to low continuous tensile strain for 4 h ( Rath-
Deschner et al., 2009). Saggese et al. found a fivefold increase of IGF-I in the 
cervicular fluid after insertion of an orthodontic appliance to distalize canines in 
patients aged between 8 and 15 years (Saggese et al., 2005). Toia et al. found that IGF-
I increases in the cervicular fluid as early as 4hrs after insertion of fixed appliances 
(Toia et al., 2005). Therefore, this study indicates that IGF-I and its signals involved in 
the mechanotransduction processes during the tooth movement. 
In this study, the character of IGF-I over time was observed in the PDL and 
found that IGF-I-positive cells were significantly increased at the tension side in a time 
dependent manner.  It was also recognized that this increase correlated with an 
increase in the total number of PDL cells over time at the same side. The both IGF-I-
positive cells and the total number of the PDL cells reach their peak points after 24 hrs.  
It has been observed that the mitotic activity of PDL cells increases markedly on the 
tension side from 24 to 36 hrs after the initiation of tooth movement (Macapanpan et 
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al., 1954). This leads to increase the number of periodontal ligament cells, which can 
be increased by stimulating cell proliferation or by inhibiting apoptosis (Suri and 
Taneja, 2008). These cell functions can be affected through IGF-I production. IGF-I 
stimulates proliferation of PDL fibroblast (Palioto et al., 2004), cementoblasts (Grzesik 
and Narayanan, 2002) and osteoblasts (Wergedal et al., 1990). 
The autocrine/paracrine secreted IGF-I is also an important component of the response 
to injury. Multiple studies in several different animal models have shown that IGF-I is 
synthesized after injury by the cell types that account for tissue regeneration.  This 
synthesis is necessary for normal tissue repair (Clemmons and Maile 2005), defends 
against cellular stress and delays the onset of the apoptosis (Kumasheva and 
Houghton, 2006). The antiapoptotic action of IGFs was recently also observed in PDL 
cells that respond to IGF-I by up-regulation of anti-apoptotic pathways (Han and 
Ammar, 2003). Therefore, one can presume that the up-regulation of IGF-I on the 
tension side can increase the cell number of PDL through its impacts on the 
proliferation and the apoptosis of the PDL cells during the tooth movement in a time-
dependent manner. 
The mean values of immunopositive cells for all examined factors reach the 
peak point after 24 hrs compared with those of the control teeth. These results are in 
accordance with those described by other researchers for other factors. Transforming 
growth factor-β1 (TGF-β1) regulates cell proliferation, differentiation, motility and 
apoptosis (Kanaan and Kanaan, 2006). Osteoprotegerin (OPG) inhibits the 
differentiation and stimulates the apoptosis of the osteoclasts (Tyrovola et al., 2008).  
These both factors were observed with significant increase in stretched cells on the 
bone surface after 24 hrs from force application and became more intense after 48 hrs 
of force application (Kobayashi et al., 2000).  
The expression of epidermal growth factor (EGF) and its receptor, which play an 
important role in bone formation, were detected in periodontal tissues after 24 hours 
and 168 hours of tooth movement. The expressions of EGF and EGFR were increased 
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in periodontal tissues at 168 hrs higher than those at 24 hrs and at tension side higher 
than those at pressure side at the same time (Gao et al., 2002). 
The expression patterns of Ki-67, a cellular marker for proliferation and osteoblast 
precursors (Scholzen and Gerdes et al., 2000), and Runx2, an essential transcription 
factor for osteoblast differentiation and chondrocyte maturation (Komori, 2011), were 
investigated at 3 and 24 hours after appliance insertion. The results showed that the 
expression of Ki-67 and Runx2 increase in the tension areas after 24 hours of force 
application (Brooks et al., 2009). 
Recently, the gingival crevicular fluid (GCF), which can be collected from the gingival 
crevice surrounding the teeth, was used to determine possible changes in its 
constituent in response to various pathological and physiological alterations in the 
periodontium (Lamster et al., 2007). The presence/expression of regulatory proteins in 
the GCF has been examined to illustrate the involvement of these proteins in 
periodontal remodeling provoked by orthodontic stimuli. The most consistent result 
was a peak of cytokine levels at 24 h (Ren and Vissink, 2008). For example, Nishijima 
et al., have examined the secretion of RANKL and OPG from hPDL cells at the distal 
cervical margins of the experimental and control teeth 0, 1, 24, and 168 hrs after the 
retracting force was applied. After 24 hrs, the levels of RANKL were significantly 
higher and the levels of OPG were significantly lower compared to the control teeth. 
There were no such significant differences at 0, 1, or 168 hrs (Nishijima et al., 2006). 
All these results support the statement that cellular and tissue reactions, including IGF-
I synthesis, start in the initial phase (1-2 days) of tooth movement, immediately after 
force application. The complex processes of recruitment of osteoclast and osteoblast 
progenitors begin in this early phase (Krishnan and Davidovitch, 2006). 
The human PDL cells represent a heterogeneous cell population including stem 
cells (Lekic et al., 2001; Silvério et al., 2010) and have the potential to differentiate 
into various phenotypes, including osteoblasts (Gay et al., 2007) and cementoblasts 
(Seo et al., 2004). IGF-I induces many differentiated functions, such as production of 
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collagen and matrix apposition (Grzesik and Narayanan, 2002; Minuto et al., 2005). It 
is known that procollagen type I is an indicator of the early stage of bone formation. 
The recombinant IGF-I can raise the serum levels of procollagen type I significantly 
(Zofkova, 2003). Therefore, it is assumed that IGF-I activates especially the early 
stages of osteoblastic formation in the PDL. 
In periodontal regeneration, the reestablishment of the PDL is required together with 
corresponding cementum and supporting alveolar bone. Thus, agents that promote 
PDL cells proliferation and migration as well as collagen biosynthesis would appear to 
be mediators for enhancing new PDL formation (Raja et al., 2009). Recently, in two in 
vitro studies, IGF-I alone or in combination with other growth factors promoted 
osteogenesis of the PDL cells. It can elevate the osteoblastic markers such alkaline 
phosphatase (ALP) and ostetocalcin (OCN) (Chen et al., 2009; Li et al., 2011). IGFs 
regulate, in diverse patterns, the differentiation functions of both osteoblasts and 
osteoclasts (Conover, 2000). This can accelerate the differentiation of osteoclasts and 
its disappearance in the tension side after force application (disto-coronal areas), which 
tend to contain more osteoclasts in the PDL of untreated teeth due to the physiological 
distal drift of the molars in the rats. 
Therefore, one can speculate that the up-regulation of IGF-I could influence the 
differentiation of the PDL cells at the tension side.  
As previously mentioned in the introduction, there are four essential interrelated 
steps in the transduction of mechanical signals by tissues: sensing the mechanical 
signal by the cells, transduction of this mechanical signal into one that is biochemical, 
transmission of the biochemical signal to the effector cells, and the effectors cell 
response (Wise and King, 2008). 
After force application both matrix strain and fluid flow in the PDL and the bone cause 
deformation of cells. Through integrin signalling and other transduction pathways, 
many mediators are produced leading to activate several types of cells (Hennemann et 
al., 2008). 
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Ajubi et al. investigated the signal transduction pathways in osteocytes which were 
subjected to pulsating fluid flow (PFF). They found that PFF raises intracellular Ca
2+
. 
Ca
2+
 and protein kinase C then stimulate phospholipase A2 activity, arachidonic acid 
production, and ultimately prostaglandin E2 (PGE2) release (Ajubi et al., 1999; Wise 
and King, 2008). 
Studies which were performed in gingival crevicular fluid (GCF) during tooth 
movement showed  that the concentration of PGE2 in GCF increased significantly and 
reaches peak point at 24th hour and generally was higher in tension sides than at the 
compression sides (Yao et al., 2003; Dudic et al., 2006). 
Release of PGE2 is a prominent load-induced response of osteoblast-like cells. PGE2 is 
produced by osteoblasts in response to physiological stress, growth factors, hormones, 
trauma or inflammatory cytokines and induces cAMP-dependent IGF-I expression by 
osteoblasts (Papachroni et al., 2009). 
In vitro studies showed that PGE2 increases rapidly at 5min after loading of teeth and 
led to an increase of intracellular cyclic adenosine monophosphate (cAMP) which 
peaks at 15 min. (Meikle, 2006).  
The increased intracellular cAMP activates protein kinase A (PKA), which stimulates 
IGF-I gene induction (McCarthy and Centrella, 2001). In addition, mechanical 
interactions between integrins and their matrix/environment mediate increases in 
intracellular Ca
2+
 levels and activate mitogen-activated protein (MAP) kinase 
cascades. This leads to the activation of the activator protein 1 (AP-1) that is necessary 
for a pro-growth response. The pro-bone growth response involves up-regulation of 
the genes c-fos, osteocalcin, cyclooxygenase, and IGF-I (Iqbal and Zaidi, 2005). 
and thus can man better understand the mechanism of IGF-I up regulation after tooth 
movement as response to up regulation of other factors such as PGE2. 
In this study, immunoreactivity for IGF-IR was generally more pronounced than 
that for its ligand IGF-I. The biological actions of IGF-I are predominantly mediated 
by the IGF-IR (LeRoith 2000; Romano, 2003; Annunziata et al., 2011).  
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Recently, it has been reported, that growth factor receptors can be also activated by 
integrins in the absence of the growth factor ligands, due to the interaction between 
integrins and growth factor receptors (Clemmons and Maile, 2003; Beattie et al., 
2010). The crosstalk between integrins and growth factor receptors in multiple cell 
types may be the result of coclustering of these receptors on the surface of the cell in 
focal adhesions or in association with the actin cytoskeleton (Eliceiri, 2001, Beattie et 
al., 2010). For example, the occupation of the αVβ3 integrin receptor with ECM 
proteins induces IGF-I-stimulated IGF-IR phosphorylation.  Conversely, the presence 
of the αVβ3-specific disintegrin echistatin inhibits the IGF-I-stimulated IGF-IR 
activation (Kim et al., 2007). In this context, Kapur et al. found that echistatin reduced 
not only the basal and shear stress-induced TE85 cell (osteosarcoma cell) proliferation 
but also completely abolished the increase in cell proliferation induced by IGF-I alone 
as well as that by the combination treatment. This suggests that the synergy between 
shear stress and IGF-I in osteoblast proliferation involves integrin-dependent 
recruitment of SHP-2 and -1 away from IGF-IR (Kapur et al., 2005). 
Insulin receptor substrates (IRS) is a main target molecule of insulin/IGF-1 
receptor signaling and plays important roles in maintaining normal bone turn-over 
(Ogata and Kawaguchi, 2008). When the concentrations of IRS1 are high, the signal is 
mitogenic and anti-apoptotic (Valentinis and Baserga, 2001). IRS1 deficient mice 
exhibited severe low turnover osteopenia with decreased bone anabolic and catabolic 
action (Akune, 2004). 
Tyrosine phosphorylation of IRS1 by the IGF-I receptor tyrosine kinase leads to 
activation of pathways such PI3 and extracellular signal-regulated kinase 1/2 
(ERK1/2). The first pathway protects from apoptosis by blocking the pro-apoptotic 
proteins and inducing the expression of antiapoptotic proteins. The second pathway, 
ERK1/2, is required for optimal stimulation of cell division (proliferation) and gene 
expression (Jones and Clemmons, 1995; Mauro and Surmacz, 2003; Yamagushi et al, 
2005). The application of orthodontic loading within the same time interval and under 
identical experimental circumstances induced a significant increase of ERK1/2-
positive PDL cells at the tension side (Kawarizadeh et al., 2005, Pavlidis et al., 2009). 
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It most kept in mind that ERK1/2 can be activated by other molecules like integrin 
receptors (Iqbal and Zaidi, 2005; Meikle, 2006). 
However, the ability of cells to respond to the autocrine/ paracrine secreted 
IGF-I is dependent not only on the amount of growth factor that is secreted, but also 
on the abundance of other proteins in the extracellular environment especially IGFBPs. 
IGFBPs are a family of secreted proteins that bind IGF with high affinities that are 
equal to or greater than those of the IGF-IR. In the extracellular environment the most, 
if not all, of IGFs are bound to specific, high-affinity IGFBPs (Duan and Xu, 2005). 
They can suppress or enhance the cellular effects of IGFI (Yu and Rohan, 2000; Firth 
and Baxter, 2002). Anyway, the observed up-regulation of the IGF-IR and IRS1 in this 
study strengthens the view that the biological action of IGF-I on PDL cells was 
stimulated under this condition of force application. 
At the pressure side, it was observed that all factors are significantly down 
regulated in the 4 hrs groups, but not in 24 or 48 hrs groups, where the differences 
between the groups were no more significant. This may be caused by virtue that PDL 
cells subjected to tensional and compressive
 
forces are able to perceive two different 
forms of mechanical
 
stimuli and responded in a different manner (He et al., 2004). 
Other interpretation for down regulation of IGF-I at the pressure side could due to the 
negative strain that induced within the PDL at the pressure side of the root 
(Hennemann et al., 2008) and, consequently, the fibers are relaxed. This leads to 
unloading of the PDL and alveolar bone (Melsen , 1999, 2001; Binderman et al., 
2002). The unloading reduces canalicular fluid flow and induces the apoptosis of 
osteocytes and osteoblasts, which attracts osteoclasts to the pressure side followed by 
bone resorption subsequently (Burger et al., 2003; Aguirre et al., 2006; Dufour et al., 
2007; Hennemann et al., 2008). Unloading could also inhibit the proliferation and 
differentiation of osteoprogenitor cells in vitro (Kostenuik et al., 1997). Moreover, 
skeletal unloading induces resistance to IGF-I on bone formation and inhibits the 
activation of the IGF-I signaling pathway (Sakata et al., 2003, 2004).  
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Clinically, skeletal unloading during space flight and prolonged bed rest induces 
osteopenia (Bikle and Hallaoran, 1999). 
Thus, one can assume that there is a relation between the unloading of PDL cells, the 
initial decrease of IGF-I-positive cells, and the decrease of the total cell number at the 
pressure side. 
The positive PDL-cells at the pressure side decreased in the 4 hrs group and 
augmented subsequently in 24 and 48 hrs groups. This could be interpreted as result of 
the remodeling activity of PDL tissue and alveolar bone at the pressure side that 
degrade to create space for the moving tooth while new PDL tissue is simultaneously 
formed to maintain the attachment (Hennemann et al. 2008). 
At the cellular level, PDL cells in the pressure side become a round shape in the first 
hours of treatment and regain a normal shape 2 or 3 days later (Kirshnan and 
Davidovitch, 2006). In this regard, cells which are rounded up show catabolic changes 
whereas flattened cells (under tension) have anabolic effects (Roberts-Harry and 
Sandy, 2004). 
In the present study, the effect of the force magnitude on the positive cells 
number was only significant between the groups, where 0.1N and 0.5N were applied 
for 4 hrs and only for IGF-IR. The results for IGF-I and IRS1 showed no significant 
differences between applied forces but tend to be negative dependent on the force 
magnitude. These results could indicate a relation between the expression of these 
molecules, especially IGF-IR, and the magnitude of the applied forces.  
In the past 70 years, the concept of optimal force has changed considerably. According 
to Schwarz, who defined optimal continuous force as „the force leading to a change in 
tissue pressure that approximated the capillary vessels‟, forces below the optimal level 
cause no reaction in the periodontal ligament. Forces exceeding the optimal level 
would lead to areas of tissue necrosis, preventing frontal bone resorption. Tooth 
movement would thus be delayed until undermining resorption had eliminated the 
necrotic tissue obstacle (Schwarz, 1932). Oppenheim and Reitan modified this 
61 
 
 
 
 
definition and advocated the use of the lightest force which is capable to achieve the 
tooth movement (Oppenheim, 1942; Reitan, 1967). The current concept of optimal 
force is based on the hypothesis, that a force of a certain magnitude and temporal 
characteristics would be capable of producing a maximum rate of tooth movement 
without tissue damage and with maximum patient comfort. The optimal force for tooth 
movement may differ for each tooth and for each individual patient (Ren et al., 2003). 
There are many reports about the effect of force magnitude on tooth movement. King 
et al. demonstrated that the effective tooth movement of rat molars ranges from 20 g to 
40 g and its velocity does not increase over 40 g (King et al., 1991). Gonzales et al. 
found that the light forces produce more tooth movement and less root resorption 
compared with heavier forces (Gonzales et al., 2007).  
Considering the orthodontic tooth movement as the result of biological reactions to 
externally applied mechanical stimuli, the application of 0.1 N may cause greater 
biologic activity of IGF-I-signalling than the other forces, which can subsequently lead 
to cellular responses aiming at adaptation to the applied forces. 
 
 
 
 
 
 
 
 
 
 
 
 
 
62 
 
 
 
 
7. Summary 
 
The aim of this study was to characterize the role of IGF-I and its signalling in vivo as 
an early reaction to the mechanotransduction process, and to analyse the changes of 
the local expression of these factors related to the magnitude of the applied force. 
The right upper first molars of 20 anesthetised rats were loaded with forces in order to 
be moved mesially. In the first group of animals, constant forces for 4 hours of 0.1 N, 
0.25 N and 0.5 N were applied in four animals each. The applied forces were kept 
constant and recorded continuously for 4 hrs. After 4 hrs all 12 animals were 
sacrificed. In the second group, constant forces of 0.1 N were applied for 2 hours in 8 
animals. Afterwards, the first and second molars in the second group were passively 
separated with composite and the occlusal contacts were eliminated by slicing the 
antagonistic lower molars. Four rats were sacrificed after 24 hrs and four after 48 hrs. 
The untreated contralateral molars in 4 rats served as controls. Paraffin-embedded 
sections of the resected jaws were prepared for immunohistochemistry to localize 
insulin-like growth factor-I (IGFI), its receptor (IGF-IR), and insulin receptor substrate 
1 (IRS1). Histomorphometric analysis was performed to count the percentage of 
immunoreactive cells in different parts of the periodontal ligament. The statistical 
analyses were performed with SPSS Software. 
The results showed that IGF-I-, IGF-IR- and IRS1-positive cells were observed in the 
periodontal tissues of the control and loaded teeth. In the experimental group, the 
number of IGF-I-, IGF-IR- and IRS1-positive cells increased significantly on the 
tension side and decreased significantly on the compression side. The increase of 
immunopositive cells at the tension side was in a time-dependent manner and tended 
to be dependent on the force magnitude. The decrease in the immunopositive cells at 
the pressure side was only observed in the first group (4 hrs) and tended to be 
dependent on the force magnitude. 
These data indicate a close relationship between mechanical loading of the PDL and 
the autocrine/paracrine expression of IGF components as an early step in the 
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mechanotransduction process leading to an organized remodelling of the PDL and 
alveolar bone in the long term. 
Moreover, the local increase/decrease of IGF-I appears to provide a link between the 
mechanical loading/unloading, the activation/inhibition of proliferation and 
differentiation of PDL cells and the inhibition/induction of the antiapoptotic activity in 
the periodontal ligament in the early phase of tooth movement. However, more studies 
are required to confirm or rule out these hypotheses. 
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